Merck & Co Inc (MRK)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$79.25

Buy

$79.27

arrow-up$3.29 (+4.33%)

Prices updated at 12 May 2025, 15:06 EDT

Prices minimum 15 mins delay

Prices in USD

Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.

S&P 500

2.67%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - General

Chairman

Mr. Robert M. Davis

CEO

Mr. Robert M. Davis

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

75,000

Head office

126 East Lincoln Avenue

Rahway

United States

07065

+1 908 740-4000

investor_relations@merck.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Douglas M. Baker, Jr Independent Director	0.13m
Mr. Inge G. Thulin Independent Director	0.12m
Mr. Richard R. DeLuca, Jr Executive Vice President and President, Merck Animal Health	0.96m
Ms. Patricia F. Russo Independent Director	0.14m
Mr. Robert M. Davis Chairman of the Board, President and Chief Executive Officer	1.62m
Mr. Thomas Henry Glocer Lead Independent Director	0.19m
Ms. Pamela J. Craig Independent Director	0.15m
Dr. Risa J. Lavizzo-Mourey,M.D. Independent Director	0.12m
Ms. Kathy J. Warden Independent Director	0.13m
Dr. Paul B. Rothman, M.D. Independent Director	0.15m
Ms. Betty D. Larson Executive Vice President and Chief Human Resources Officer	0.60m
Mr. Sanat Chattopadhyay Executive Vice President and President, Merck Manufacturing	-
Ms. Mary Ellen Coe Independent Director	0.12m
Mr. Chirfi Guindo Senior Vice President, Human Health and Chief Marketing Officer	-
Ms. Jennifer Zachary Executive Vice President and General Counsel	-
Ms. Caroline A. Litchfield Executive Vice President and Chief Financial Officer	1.17m
Dr. Christine E. Seidman, M.D. Independent Director	0.13m
Mr. David Michael Williams Executive Vice President and Chief Information and Digital Officer	-
Dr. Stephen L. Mayo, PhD Independent Director	0.13m
Mr. Dean Y. Li, M.D.,PhD Executive Vice President and President, Merck Research Laboratories	1.45m
Mr. Michael A Klobuchar Executive Vice President and Chief Strategy Officer	-
Ms. Cristal N. Downing Executive Vice President and Chief Communications and Public Affairs Officer	-
Mr. Jannie Oosthuizen Senior Vice President and President, Merck U.S. Human Health	-
Mr. Joseph Romanelli Senior Vice President and President, MSD, International Human Health	-
Mr. Dalton E. Smart, III Senior Vice President, Finance, Global Controller and Principal Accounting Officer	-
Mr. Surendralal L. Karsanbhai Independent Director	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	251,096,107
BlackRock Inc	222,081,845
State Street Corp	120,909,306
BlackRock Fund Advisors	89,634,379
Vanguard Investments Australia Ltd	81,646,221

Director dealings

Date chevron-l-regular chevron-r-regular	Action
30 Sep 2024	-
30 Sep 2024	-
30 Sep 2024	-
05 Aug 2024	-
05 Aug 2024	-
05 Aug 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.